Magnesium & DR Risk - Summary - MDSpire

Magnesium & DR Risk

  • May 29, 2026

Share

Objective:

To investigate the association between serum magnesium levels and diabetic retinopathy (DR) in patients with type 2 diabetes.

Key Findings:
  • Low serum magnesium levels are significantly associated with diabetic retinopathy.
  • Individuals with DR had lower circulating magnesium levels than controls.
  • Reduced magnesium levels were consistently observed across multiple subgroups.
  • Patients with proliferative diabetic retinopathy exhibited lower magnesium levels compared to those with non-proliferative disease.
Interpretation:

Limitations:
  • The evidence is observational with low certainty due to significant heterogeneity.
Conclusion:

Original Source(s)

Magnesium & DR Risk

  • May 29, 2026

Related Content

The Fight for Research Integrity Needs You

Elisabeth Bik has built a career exposing problematic papers. Now she is asking analytical scientists to apply the same scrutiny to their own fields.

Grip Strength Plus Waist Size May Flag Risk T2D Risk

Researchers found that patients with higher waist circumference and lower grip strength had the greatest risk for developing type 2 diabetes during long-term follow-up.

Mass Spec Roundup: Structure Searching Comes to Metabolomics 

Mass spectrometry brings new detail to searchable metabolites, dynamic protein pockets, ancient hominin proteins, and plant chemistry 

  • May 20, 2026

  • 6 min